Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Labcorp
|
| gptkbp:CEO |
Paul Kirchgraber
|
| gptkbp:division |
gptkb:Labcorp
|
| gptkbp:formerName |
gptkb:Covance
|
| gptkbp:foundedYear |
1968
|
| gptkbp:headquartersLocation |
gptkb:Princeton,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Labcorp Drug Development
|
| gptkbp:industry |
contract research organization
pharmaceutical services |
| gptkbp:notableProject |
COVID-19 clinical trials
|
| gptkbp:numberOfEmployees |
over 20,000
|
| gptkbp:operatesIn |
global
|
| gptkbp:parentCompany |
gptkb:Labcorp
|
| gptkbp:service |
clinical trials
preclinical research toxicology testing central laboratory services drug development consulting |
| gptkbp:stockSymbol |
LH (as part of Labcorp)
|
| gptkbp:website |
https://drugdevelopment.labcorp.com/
|
| gptkbp:bfsParent |
gptkb:IQVIA
gptkb:contract_research_organization gptkb:contract_research_organizations |
| gptkbp:bfsLayer |
7
|